Murphy Nicole

Murphy Nicole is listed in filings as Head of Pharm Ops and Tech at Biogen Inc. This profile follows SEC Form 4 activity through Feb 17, 2026, including purchase activity. Recent filings connect the profile to Biogen Inc (BIIB). The current snapshot covers public activity from Feb 10, 2025 to Feb 17, 2026. Reported amounts are shown as $585 to $204.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.